---
category: news
title: "Investment fuels AI-driven development of breakthrough genomic medicines"
excerpt: "David Del Bourgo (CEO and co-founder, Whitelab Genomics) has always been passionate about introducing disruptive, innovative technologies to markets. Now he leads Whitelab Genomics as its artificial intelligence (AI) platform powers the development of genomic therapies â€“ an emerging field in which genetic sequences are injected into cells to target and repair damaged genes."
publishedDateTime: 2022-10-12T07:00:00Z
originalUrl: "https://pharmaphorum.com/digital/investment-fuels-ai-driven-development-of-breakthrough-genomic-medicines/"
webUrl: "https://pharmaphorum.com/digital/investment-fuels-ai-driven-development-of-breakthrough-genomic-medicines/"
type: article
quality: 38
heat: 38
published: false

provider:
  name: pharmaphorum
  domain: pharmaphorum.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://pharmaphorum.com/wp-content/uploads/2022/10/iStock-1363666077.jpg"
    width: 1200
    height: 675
    isCached: true

secured: "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;QNyjOVxzcpx5iAdwotXtJg=="
---

